Johnson & Johnson Must Pay Dying Cancer Patient $417M

Posted August 23, 2017

Of five previous cases-all tried in Missouri state court in St. Louis-J&J lost four, with combined damage awards of about $305 million.

The company immediately announced it would seek to overturn Monday's verdict, saying science supports the safety of the Johnson's Baby Powder.

The company argued that federal agencies like the Food and Drug Administration have not ruled talc to be carcinogenic.

Echeverria claimed she had developed ovarian cancer after using products such as Johnson's baby powder, which she claimed she had used since she was 11 years old.

The New Jersey-based company, which is litigating 5,500 claims in the United States over its talc products, says it will appeal the jury's ruling.

TALC TALK As Johnson & Johnson fork out £85MILLION in latest cancer case, should you avoid baby powder?

The American Cancer Society has said research linking women's use of talcum powder in the genital area to ovarian cancer has been "mixed, with some studies reporting a slight increased risk and some reporting no increase".

In a decision in a case involving Bristol-Myers Squibb Co, the Supreme Court said state courts can not hear claims against companies that are not based in the state when the alleged injuries did not occur there.

The mineral talc in its natural form does contain asbestos and does cause cancer, however, asbestos-free talc has been used in baby powder and other cosmetics since the 1970s.

He also said, "She really didn't want sympathy".

There have been several cases in the past as well where women have complained that they developed cancer after they used the firm's products to address concerns about vaginal odour and moisture.

J&J said it plans to appeal against the case.

The plaintiff's attorney said he thinks the jury was swayed in part by Johnson & Johnson's own documents, dating back to 1964, that discuss the risk of using talcum powder for feminine hygiene.

In her tearful testimony, she talked about how her daughter cared for her after her diagnosis 10 years ago.

Goodrich said the company is preparing for additional trials in the USA and will continue to defend the product's safety.

It is also not the first time that Johnson & Johnson's talc-powder products have brought negative publicity for the company. There are more than 300 of the lawsuits pending in California and more than 4,500 claims in the rest of the country that alleged the company knew about the link between the powder and ovarian cancer.